Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
59,000
Employees59,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
59,000
Employees59,000

BSX Key Statistics

Market cap
72.16B
Market cap72.16B
Price-Earnings ratio
20.48
Price-Earnings ratio20.48
Dividend yield
Dividend yield
Average volume
28.05M
Average volume28.05M
High today
$50.14
High today$50.14
Low today
$48.28
Low today$48.28
Open price
$49.47
Open price$49.47
Volume
20.26M
Volume20.26M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$47.17
52 Week low$47.17

Stock Snapshot

With a market cap of 72.16B, Boston Scientific(BSX) trades at $48.46. The stock has a price-to-earnings ratio of 20.48.

During the trading session on 2026-06-06, Boston Scientific(BSX) shares reached a daily high of $50.14 and a low of $48.28. At a current price of $48.46, the stock is +0.4% higher than the low and still -3.4% under the high.

Trading activity shows a volume of 20.26M, compared to an average daily volume of 28.05M.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $47.17.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $47.17.

BSX News

TipRanks 19h
Boston Scientific: Buy Rating Reiterated as Long-Term Growth Story Intact and $68 Price Target Reaffirmed

In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Boston Scientific, with a price target of $68.00. Claim 55%...

Nasdaq 2d
Boston Scientific Rises Higher Than Market: Key Facts

The latest trading session saw Boston Scientific (BSX) ending at $89.86, denoting a +1.02% adjustment from its last day's close. This move outpaced the S&P 500'...

Boston Scientific Rises Higher Than Market: Key Facts
TipRanks 2d
Boston Scientific price target lowered to $64 from $85 at Truist

Truist lowered the firm’s price target on Boston Scientific (BSX) to $64 from $85 and keeps a Buy rating on the shares. The firm notes the recent management com...

Analyst ratings

86%

of 35 ratings
Buy
85.7%
Hold
14.3%
Sell
0%

More BSX News

Simply Wall St 3d
Boston Scientific Repricing As Watchman Slowdown Tests Growth And Moat

Boston Scientific (NYSE:BSX) reported a critical slowdown in its Watchman device business, a key contributor to company earnings. Management recently signaled...

Boston Scientific Repricing As Watchman Slowdown Tests Growth And Moat
TipRanks 4d
Boston Scientific put volume heavy and directionally bearish

Bearish flow noted in Boston Scientific (BSX) with 8,246 puts trading, or 2x expected. Most active are Jun-26 47.5 puts and 6/5 weekly 47.5 puts, with total vol...

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.